Study patients received subcutaneous darbepoetin alfa 6.75 ... Although they are effective, thrice-weekly or weekly regimens of epoetin alfa can pose an economic burden on patients with persistent ...

According to the results of a single-center, prospective, crossover study, darbepoetin alfa—a hyperglycosylated, and therefore longer-acting, derivative of epoetin—is a more effective ...

Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting was studied. Methods: The study was an observational, retrospective review of the hospitalwide use of ...

It also offers less frequent dosing, given as a subcutaneous injection once every ... and concurrent haemoglobin increase compared to epoetin alfa," he added. BMS is also testing Reblozyl in ...